1: Jia L, Hu C, Wang H, Liu Y, Liu X, Zhang YY, Li W, Wang LX, Cao YF, Fang ZZ. Chirality Influence of Zaltoprofen Towards UDP-Glucuronosyltransferases (UGTs) Inhibition Potential. Chirality. 2015 Jun;27(6):359-63. doi: 10.1002/chir.22436. Epub 2015 Apr 22. doi: 10.3109/08982104.2015.1120746. Epub 2016 Jan 19. doi: 10.1002/jps.24543. Epub 2015 Jun 17. doi: 10.1016/j.ijpharm.2013.05.059. Epub 2013 Jun 4. doi: 10.1016/j.intimp.2013.05.008. Epub 2013 May 27. doi: 10.15171/apb.2015.073. Epub 2015 Nov 30. 8: Shah HA, Patel RP. Statistical modeling of zaltoprofen loaded biopolymeric nanoparticles: Characterization and anti-inflammatory activity of nanoparticles loaded gel. Int J Pharm Investig. 2015 Jan-Mar;5(1):20-7. doi: 10.4103/2230-973X.147229. 9: Wang H, Ji J, Zeng S. Biosynthesis and stereoselective analysis of (-)- and (+)-zaltoprofen glucuronide in rat hepatic microsomes and its application to the kinetic analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Aug 15;879(24):2430-6. doi: 10.1016/j.jchromb.2011.06.043. Epub 2011 Jul 6. doi: 10.1213/ANE.0b013e31821c693c. Epub 2011 Apr 25.